Protagonist Therapeutics Inc (PTGX) financials · rev $46.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Protagonist Therapeutics Inc (PTGX) rev $46.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $46.0M | $434.4M |
| Operating Income | -$158.1M | $252.8M |
| Net Income | -$130.1M | $275.2M |
| EPS (Diluted) | -$2.05 | $4.23 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $668.2M | $744.7M |
| Current Assets | $577.6M | $591.6M |
| Cash & Equivalents | $128.4M | $97.2M |
| PP&E | $3.86M | $3.19M |
| Total Liabilities | $53.5M | $69.4M |
| Current Liabilities | $45.4M | $47.4M |
| Shareholders' Equity | $614.7M | $675.3M |
| Retained Earnings | -$470.7M | -$340.5M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $57.7M | $184.2M |
| CapEx | $1.59M | $1.35M |
| Investing Cash Flow | -$49.3M | -$299.5M |
| Financing Cash Flow | $22.9M | $25.9M |
| Net Change in Cash | $31.2M | -$89.5M |
| Free Cash Flow | $56.1M | $182.8M |
FAQ
What is PTGX P/E and revenue?
Protagonist Therapeutics Inc (PTGX) rev $46.0M.
What is PTGX revenue?
Protagonist Therapeutics Inc last cached revenue is $46.0M (FY2025).
Is PTGX profitable?
Protagonist Therapeutics Inc last cached net income is -$130.1M (FY2025).
What are PTGX total assets?
Protagonist Therapeutics Inc last cached total assets are $668.2M (FY2025).
What is PTGX free cash flow?
Protagonist Therapeutics Inc last cached free cash flow is $56.1M (FY2025).
Not investment advice. Cached statements, not a live tape.